Sara Lee Corp. has received an offer from SC Johnson to acquire Sara Lee’s global shoe care business, including the venerable Kiwi brand, for 245 million euros ($327.9 million). Sara Lee said Monday that the binding offer also includes the Kiwi Kleen, Bama, Tana and Meltonian brands.
ECRM has launched a series of reports and a blog that examine retail circular advertising. The new resources are designed to provide a unique perspective on retail promotions from more than 160 retailers in the United States and Canada.
Endo Pharmaceuticals has obtained Food and Drug Administration clearance to market Fortesta Gel for topical use to treat men with low testosterone.
Impax Laboratories Inc. has received final approval from the Food and Drug Administration for 75-mg and 100-mg doxycyline hyclate delayed-release tablets, a generic version of the antibacterial medication Doryx.
Frito-Lay North America plans to make about 50% of its product portfolio with all-natural ingredients and has begun shipping the first natural snacks to retailers. The PepsiCo division said Tuesday that the strategy includes three of its biggest brands: Lay’s, Tostitos and SunChips.
Coty Inc. is launching a wide range of Sally Hansen beauty implements and nail care products in the first quarter, including polish, polish strips, gel treatments and growth serum. The company is also rolling out new Sally Hansen hand creams, foot care products, lip treatments and a depilatory.
Nice-Pak Products Inc. has transformed its Mooresville, Ind., manufacturing plant into what it calls a “zero landfill” facility. The move, expected to keep more than 4,200 tons of waste a year from going into landfills, is the second transformation of a Nice-Pak facility in the past six months.
Cephalon Inc. has appointed J. Kevin Buchi as chief executive officer and a member of the biopharmaceutical company’s board. The move comes following the death of Cephalon founder, chairman and CEO Frank Baldino Jr. earlier this month at age 57 from complications related to leukemia.
Gardasil, Merck’s vaccine for human papillomavirus (HPV), has been approved by the Food and Drug Administration for the prevention of anal cancer and anal intraepithelial neoplasia (AIN).
Watson Pharmaceuticals next year plans to roll out a chewable, low-dose oral contraceptive that the company called a new option for birth control.
Novartis has received approval from the Food and Drug Administration for Amturnide tablets for the treatment of high blood pressure.
The Pharmaceutical Research and Manufacturers of America (PhRMA) this week announced the election of four new members to its board of directors. PhRMA said Tuesday that the new board members are Ian Read, president and chief executive officer of Pfizer Inc.; Jerzy Gruhn, president Novo Nordisk Inc.
Abbott Diabetes Care has begun a recall of 359 lots of various brands of blood glucose test strips in the United States and Puerto Rico.
Olay has introduced the Olay Professional Pro-X Advanced Cleansing System, which the Procter & Gamble Co. skin care brand said is first at-home facial cleansing tool that cleans and exfoliates as effectively as a professional cleansing system.
Manchester College in northern Indiana has received a $35 million grant from Lilly Endowment to launch a school of pharmacy.
Emisphere Technologies Inc. and Novo Nordisk A/S have teamed up to develop oral formulations of insulin for diabetes.
